ESC Premium Access

Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus

Congress Session

About the speaker

Doctor David Berg

Brigham and Women's Hospital, Boston (United States of America)
2 presentations
0 follower

3 more presentations in this session

State of the Art in antidiabetic treatment to prevent CVD

Speaker: Professor A. Norhammar (Stockholm, SE)

Thumbnail

Albuminuria as a predictor of incident ischemic stroke and myocardial infarction in patients with type 2 diabetes but without cardiovascular disease: A Danish cohort study

Speaker: Mrs M. Fangel (Aalborg, DK)

Thumbnail

Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies

Speaker: Mrs M. Malik (Copenhagen, DK)

Thumbnail

Access the full session

The right glucose-lowering drugs for the right patient

Speakers: Doctor D. Berg, Professor A. Norhammar, Mrs M. Fangel, Mrs M. Malik
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk